Evidence map›Paper›PMID 39731452›Full record

ArticleAnnals of medicine2025

Effect of serotonin receptor gene variants on substance use disorders.

Laith Al-Eitan, Hana Abu Kharmah, Mansour Alghamdi

Abstract read
In one paragraph

Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Laith Al-EitanDepartment of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, Irbid, Jordan.ORCID 0000-0003-0064-0190
Hana Abu KharmahDepartment of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, Irbid, Jordan.ORCID 0000-0001-5094-6329
Mansour AlghamdiDepartment of Anatomy, College of Medicine, King Khalid University, Abha, Saudi Arabia.ORCID 0000-0002-6613-1498

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSubstance use disorders are multifaceted conditions influenced by both genetic and environmental factors. Serotonergic pathways are known to be involved in substance use disorder susceptibility, with genetic markers within serotonin receptor genes identified as potential risk factors.

methodsTo further explore this relationship, we conducted a study to investigate the association between several polymorphisms in five serotonin receptor genes (

resultsOur findings revealed an allelic association between rs9567735 in the

conclusionThese findings suggest that genetic variants of human 5-HT receptor genes may affect individual susceptibility to SUD in Jordan. However, further studies with larger sample sizes and additional variants in the same or different genes must confirm these findings.

Indexed as

Genetic Predisposition to DiseaseHaplotypesPolymorphism, Single NucleotideReceptors, Serotonin, 5-HT3Substance-Related DisordersAdultAllelesCase-Control StudiesGenotypeHumansJordanMaleMiddle AgedReceptor, Serotonin, 5-HT1BReceptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2BHTR1B protein, humanHTR2A protein, humanHTR3A protein, humanHTR3B protein, humanReceptor, Serotonin, 5-HT1BReceptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2BReceptors, SerotoninReceptors, Serotonin, 5-HT3geneticsPolymorphismsserotonin receptorssubstance use

Identifiers

PMID39731452
PMCPMC11703447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.